(Report ID: 69054) Drug interactions analysis of:
Lipitor, Aspirin, Furosemide, Ramipril, GemfibrozilMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,647 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 177 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 69054 | Mar, 7, 2006 | 83 | Male |
List of drugs the patient takes:
| Drug |
Lipitor |
Aspirin |
Furosemide |
Ramipril |
Gemfibrozil |
| Name |
Acute Myocardial Infarction |
Alanine Aminotransferase Increased |
Anaemia |
Angina Unstable |
Blood Creatine Phosphokinase Increased |
Difficulty In Walking |
Left Ventricular Failure |
Pain |
Renal Impairment |
Results from eHealthMe: 177 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Acute Myocardial Infarction | 5 (2.82%) |
Alanine Aminotransferase Increased | 8 (4.52%) |
Anaemia | 9 (5.08%) |
Angina Unstable | 5 (2.82%) |
Blood Creatine Phosphokinase Increased | 7 (3.95%) |
Difficulty In Walking | 2 (1.13%) |
Left Ventricular Failure | 5 (2.82%) |
Pain | 5 (2.82%) |
Renal Impairment | 4 (2.26%) |
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Pruritus | 1 (25.00%) |
2 | Drug Level Below Therapeutic | 1 (25.00%) |
3 | Visual Disturbance | 1 (25.00%) |
4 | Sepsis | 1 (25.00%) |
5 | Rash | 1 (25.00%) |
6 | Renal Failure Acute | 1 (25.00%) |
7 | Headache | 1 (25.00%) |
8 | Epistaxis | 1 (25.00%) |
9 | Pulmonary Oedema | 1 (25.00%) |
10 | Platelet Count Increased | 1 (25.00%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Lasix | 3 |
2 | Prilosec | 2 |
3 | Albuterol | 2 |
4 | Docetaxel | 2 |
5 | Flonase | 1 |
6 | Ranitidine | 1 |
7 | Dexamethasone Tab | 1 |
8 | Pamidronate Disodium | 1 |
9 | Rosiglitazone | 1 |
10 | Metformin Hcl | 1 |
Death: 4 (2.26% of total reports)
Cancer: 5 (2.82% of total reports)
| Name | Count (% of total reports) |
1 | Renal Failure Acute | 17 (9.60%) |
2 | Weight Decreased | 16 (9.04%) |
3 | Renal Failure | 15 (8.47%) |
4 | Cardiac Failure Congestive | 13 (7.34%) |
5 | Hypotension | 12 (6.78%) |
6 | Nausea | 11 (6.21%) |
7 | Myocardial Infarction | 11 (6.21%) |
8 | Blood Glucose Increased | 10 (5.65%) |
9 | Haemoglobin Decreased | 10 (5.65%) |
10 | Dizziness | 9 (5.08%) |
| Name | Count |
1 | Lasix | 105 |
2 | Altace | 91 |
3 | Plavix | 53 |
4 | Lopid | 39 |
5 | Coreg | 25 |
6 | Coumadin | 24 |
7 | Glucophage | 23 |
8 | Digoxin | 21 |
9 | Folic Acid | 20 |
10 | Prevacid | 20 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
